What is Genexa?
Genexa distinguishes itself as the first clean medicine company, offering a comprehensive range of medications for pain, fever, cough, cold, flu, allergies, digestive issues, and sleep stress, suitable for both children and adults. Their commitment to utilizing non-GMO, gluten-free, and organic ingredients, while ensuring the same efficacy as traditional medicines, has positioned them as a preferred choice for health-conscious parents and pediatricians. The company's focus on clean formulations addresses a growing consumer demand for healthier alternatives in the pharmaceutical market.
How much funding has Genexa raised?
Genexa has raised a total of $60.1M across 2 funding rounds:
Debt
$150K
Unspecified
$60M
Debt (2020): $150K with participation from PPP
Unspecified (2021): $60M led by Jared Stein, Verlinvest, and Unilever Ventures
Key Investors in Genexa
Verlinvest
Verlinvest is a privately-owned family investment company focused on investing in visionary business leaders to build global, fast-growing consumer businesses and brands, particularly in the food and beverages, digital and healthcare sectors. Established in 1995 with offices in Brussels, London, New York and Singapore, Verlinvest has over $4bn in AuM, through category-defining portfolio companies that include Oatly, Vita Coco, Mutti, Tony's Chocolonely and Hint Water.
Unilever Ventures
Unilever Ventures is an investment arm of Unilever, likely focusing on consumer goods and related technologies that align with Unilever's broader business objectives, potentially including health and wellness brands.
Jared Stein
An individual investor participating in the funding round, likely bringing strategic expertise or network connections to Genexa.
What's next for Genexa?
With the recent influx of major strategic investment and significant enterprise-level backing, Genexa is well-positioned for accelerated expansion. This capital infusion is expected to fuel further product development, enhance manufacturing capabilities, and broaden market reach. The company's focus on clean, effective medicines aligns with evolving consumer preferences, suggesting a strong potential for continued growth and market leadership in the health and wellness sector. Future initiatives will likely concentrate on scaling operations and solidifying its brand as a trusted provider of healthier pharmaceutical options.
See full Genexa company page
